Ann: CardieX China and Product Strategy Update - English, page-71

But aren't SHs here concerned after InHealth subsidiary was exposed with fake reviews. Doesn't matter it's poor form
This cooresponds to unprofessional look for the co CDX imo
No doubt twitter activity has increased from CEO to try to stem bleeding but like they say talk is cheap

I find it interesting also that immediately Cooper & Donal Dyer resigns the share price plummets

The financials of company also don't justify current marketcap imo

may see 3c imo based on above

Buyers look hesitant to up it and why would they when Broker Taylor is dumping